PEPTONIC medical ABXSAT:PMED Gross Margin % is 67.59% as of Mar. 2026, which is 14% above its 10-year median of 59.19. The stock has 6 warning signs investors should review. Among 937 Drug Manufacturers companies, PEPTONIC medical AB ranks better than 84.42% on this metric.
The historical rank and industry rank for PEPTONIC medical AB's Gross Margin % or its related term are showing as below:
XSAT:PMED'
s Gross Margin % Range Over the Past 10 Years
Min: 43.9 Med: 59.19 Max: 72.04
Current: 72.04
During the past 13 years, the highestGross Margin % of PEPTONIC medical AB was 72.04%. The lowest was 43.90%. And the median was 59.19%.
XSAT:PMED's Gross Margin % is ranked better than 84.42% of 937
companies
in the Drug Manufacturers industry
Industry Median: 48.46
vs XSAT:PMED: 72.04
PEPTONIC medical AB had a gross margin of 67.59% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for PEPTONIC medical AB was 0.10% per year.
PEPTONIC medical AB (XSAT:PMED) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PEPTONIC medical AB had a gross margin of 67.59% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PEPTONIC medical AB Gross Margin % Related Terms
PEPTONIC medical AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for PEPTONIC medical AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:PMED vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PEPTONIC medical AB Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PEPTONIC medical AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PEPTONIC medical AB (XSAT:PMED) has a Gross Margin % of 67.59% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PEPTONIC medical AB and its competitors. This is 14% above median its historical median of 59.19. Over the past decade, PEPTONIC medical AB's Gross Margin % has ranged from 43.90 to 72.04. According to the industry distribution chart, PEPTONIC medical AB ranks #146 out of 937 companies in the Drug Manufacturers industry, placing it in the top 15.6%.
Is PEPTONIC medical AB's Gross Margin % too high?
PEPTONIC medical AB's current Gross Margin % of 67.59% is 14% above median its 10-year median of 59.19. Over the past 10 years, this metric has ranged from a low of 43.90 to a high of 72.04. The Drug Manufacturers industry median Gross Margin % is 48.46. PEPTONIC medical AB's value of 67.59% is 39.5% above this industry median. Based on the distribution chart, PEPTONIC medical AB ranks #146 out of 937 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does PEPTONIC medical AB's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PEPTONIC medical AB ranks #146 out of 937 companies for Gross Margin %. This places PEPTONIC medical AB in the top 16% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.46. PEPTONIC medical AB's value of 67.59% is 39.5% above this benchmark. Historically, PEPTONIC medical AB's own Gross Margin % has ranged from 43.90 to 72.04 over the past decade. While the company's 10-year median is 59.19 vs. the industry median of 48.46, PEPTONIC medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PEPTONIC medical AB's current Gross Margin % of 67.59% is 39.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PEPTONIC medical AB and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PEPTONIC medical AB's current Gross Margin % is 67.59%, which is 14% above median its own 10-year median of 59.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (XSAT:PMED) has a current Gross Margin % of 67.59%. The current Gross Margin % is 67.59%, which is 14% above median its 10-year median of 59.19 and 39.5% above the Drug Manufacturers industry median of 48.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PEPTONIC medical AB (XSAT:PMED), the current Gross Margin % is 67.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:PMED has been successfully added to your 